Clinical Response to Apatinib Combined With Brain Radiotherapy in EGFR Wild-Type and ALK-Negative Lung Adenocarcinoma With Multiple Brain Metastases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical Response to Apatinib Combined With Brain Radiotherapy in EGFR Wild-Type and ALK-Negative Lung Adenocarcinoma With Multiple Brain Metastases

Published:2020-04-15 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Ying Xiaofang,Liu Huali,Wang Mingwei,Peng Min,Ruan Peng,Verma Vivek,Han Guang

Funder

Chinese Society of Clinical Oncology

Natural Science Foundation of Hubei Province

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference22 articles.

1. EGFR mutation status in brain metastases of non-small cell lung carcinoma;Burel-Vandenbos;J Neurooncol.,2013

2. A retrospective analysis in patients with EGFR-mutant lung adenocarcinoma: is EGFR mutation associated with a higher incidence of brain metastasis?;Han;Oncotarget,2016

3. Leukoencephalopathy after whole-brain radiation therapy plus radiosurgery versusradiosurgery alone for metastatic lung cancer;Monaco;Cancer.,2013

4. Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases;Tsao;Cochrane Database Syst Rev.,2012

5. Integrating bevacizumab and radiation treatment of brain metastasis: is there sense and sensibility in this approach?;Lou;Ann Transl Med,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of apatinib+radiotherapy vs radiotherapy alone in patients with advanced multiline therapy failure for non small cell lung cancer with brain metastasis;The British Journal of Radiology;2023-09

2. Apatinib suppresses lung cancer stem-like cells by complex interplay between β-catenin signaling and mitochondrial ROS accumulation;Cell Death Discovery;2021-05-12

3. Concurrent Apatinib and Brain Radiotherapy in Patients With Brain Metastases From Driver Mutation-negative Non–small-cell Lung Cancer: Study Protocol for an Open-label Randomized Controlled Trial;Clinical Lung Cancer;2021-03

4. Continuous Low-Dose Apatinib Combined With WBRT Significantly Reduces Peritumoral Edema and Enhances the Efficacy of Symptomatic Multiple Brain Metastases in NSCLC;Technology in Cancer Research & Treatment;2021-01-01

5. Emerging and investigational targeted chemotherapy and immunotherapy agents for metastatic brain tumors;Expert Opinion on Investigational Drugs;2020-10-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3